Bristol Myers Squibb Foundation unites with Gilead to boost diversity among clinical trial investigators

Less than 18 months after unveiling its clinical trial investigator training program, the Bristol Myers Squibb Foundation has linked up with an unlikely ally to expand enrollment, the first in a newfound effort to publicly rally more financial support.

Gilead will contribute $14 million over four years after deciding that the foundation’s career development program, which centers on elevating physicians of color, was better than what they were concocting internally, according to Catharine Grimes, senior director at the BMS Foundation. The foundation announced the funding commitment Monday.